Chen L - Search Results

1

G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.

Zhu K, Deng C, Du P, Liu T, Piao J, Piao Y, Yang M, Chen L. Zhu K, et al. Among authors: chen l. Reprod Biol Endocrinol. 2022 Mar 11;20(1):50. doi: 10.1186/s12958-022-00921-6. Reprod Biol Endocrinol. 2022. PMID: 35277194 Free PMC article.

2

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.

Kong J, Di C, Piao J, Sun J, Han L, Chen L, Yan G, Lin Z. Kong J, et al. Among authors: chen l. Oncotarget. 2016 Apr 12;7(15):19631-42. doi: 10.18632/oncotarget.7779. Oncotarget. 2016. PMID: 26933912 Free PMC article.

3

The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.

Jin H, Ji M, Chen L, Liu Q, Che S, Xu M, Lin Z. Jin H, et al. Among authors: chen l. J Exp Clin Cancer Res. 2016 Mar 9;35:42. doi: 10.1186/s13046-016-0316-0. J Exp Clin Cancer Res. 2016. PMID: 26955804 Free PMC article.

4

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC.

Piao J, Chen L, Quan T, Li L, Quan C, Piao Y, Jin T, Lin Z. Piao J, et al. Among authors: chen l. Oncotarget. 2016 Sep 13;7(37):60169-60180. doi: 10.18632/oncotarget.11109. Oncotarget. 2016. PMID: 27507059 Free PMC article.

5

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.

Chen L, Jin T, Zhu K, Piao Y, Quan T, Quan C, Lin Z. Chen L, et al. Oncotarget. 2017 Feb 14;8(7):11937-11949. doi: 10.18632/oncotarget.14442. Oncotarget. 2017. PMID: 28060760 Free PMC article.

6

Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.

Sun J, Che SL, Piao JJ, Xu M, Chen LY, Lin ZH. Sun J, et al. Tumour Biol. 2017 Mar;39(3):1010428317695918. doi: 10.1177/1010428317695918. Tumour Biol. 2017. PMID: 28349826 Free article.

7

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.

Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, Chen L. Yang Y, et al. Among authors: chen l. Sci Rep. 2017 Jun 2;7(1):2681. doi: 10.1038/s41598-017-02937-0. Sci Rep. 2017. PMID: 28578385 Free PMC article.

8

Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker.

Piao J, Chen L, Jin T, Xu M, Quan C, Lin Z. Piao J, et al. Among authors: chen l. Hum Pathol. 2018 Mar;73:33-40. doi: 10.1016/j.humpath.2017.10.037. Epub 2017 Dec 16. Hum Pathol. 2018. PMID: 29258905

9

Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.

Piao J, Sun J, Yang Y, Jin T, Chen L, Lin Z. Piao J, et al. Among authors: chen l. Gene. 2018 Mar 20;647:306-311. doi: 10.1016/j.gene.2018.01.003. Epub 2018 Jan 3. Gene. 2018. PMID: 29305979

10

Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome.

Yang Y, Wu Q, Li N, Che S, Jin T, Nan Y, Lin Z, Chen L. Yang Y, et al. Among authors: chen l. Hum Pathol. 2018 May;75:179-188. doi: 10.1016/j.humpath.2018.02.006. Epub 2018 Feb 13. Hum Pathol. 2018. PMID: 29452216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,926 results

Search Page

Filters